Form 8-K - Current report:
SEC Accession No. 0001070081-25-000026
Filing Date
2025-11-04
Accepted
2025-11-04 16:10:14
Documents
14
Period of Report
2025-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20251104x8k.htm   iXBRL 8-K 45318
2 EX-99.1 tmb-20251104xex99d1.htm EX-99.1 210772
  Complete submission text file 0001070081-25-000026.txt   387746

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20251104.xsd EX-101.SCH 3334
4 EX-101.DEF tmb-20251104_def.xml EX-101.DEF 2805
5 EX-101.LAB tmb-20251104_lab.xml EX-101.LAB 16546
6 EX-101.PRE tmb-20251104_pre.xml EX-101.PRE 9654
16 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20251104x8k_htm.xml XML 4679
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 251449099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)